Journal Guide

Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published.

The aims and objectives of Diabetes and Metabolic Syndrome: Clinical Research and Reviews are to increase knowledge, provide guidelines and policies, stimulate research about the physiology and pathophysiology, and to promote better management of the metabolic diseases, using peer-reviewed original articles and expert comments. It encourages the publication of original basic/original research articles, reviews, short communication, case reports and letters. Reviews or mini-reviews are especially welcomed for those areas within endocrinology undergoing rapid changes. Short communications should contain concise definitive information.

A high quality scientific journal with an international readershipOfficial publication of the Alfediam, Diabetes & Metabolism, publishes high-quality papers by leading teams, forming a close link between hospital and research units. Diabetes & Metabolism is published in English language and is indexed in all major databases with its impact factor up to 2.426 in 2010 (IF 2009).Diabetes & Metabolism contains original articles, short reports and comprehensive reviews. The latter are updates written by internationally recognized specialists carefully edited in order to help clinicians and researchers keep informed about the latest developments in the field of diabetes.Une revue scientifique de haute qualitéDiabetes & Metabolism réunit des articles originaux, des cas cliniques, des lettres à l'éditeur et des travaux indispensables pour la compréhension du diabète et de ses conséquences multiples, ainsi que des Recommandations de l'Alfediam. Elle est destinée aux cliniciens et aux chercheurs qui souhaitent suivre de près les récentes évolutions de la diabétologie.Une revue à diffusion internationaleDiabetes & Metabolism publie en langue anglaise les travaux des meilleures équipes francophones et étrangères de la spécialité et rencontre un facteur d'impact qui ne cesse de progresser. La revue est indexée dans les plus grandes bases de données internationales : Current Contents (Life Sciences), EMBASE (Excerpta Medica), Research Alert, SCI Search.

Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title.It mirrors the increasing recognition that diabetes and cardiovascular disease are a single entity in which diabetes and related disorders such as insulin resistance Diabetes & Vascular Disease Researchare directly linked with assaults on the vessel wall and the development of vascular risk clustering.Diabetes & Vascular Disease Research:· Links diabetes, its metabolic consequences and vascular outcomes·Original research in fields of insulin resitance and metabolic disorders· Promotes understand of pathology, aetiology and management of Thrombosis, Hyperglycaemia, Hypertension, Dyslipidaemia and Micro-and macrovascular consequences.

Diabetes Care is a journal for the health care practitioner that is intended to increase knowledge, stimulate research, and promote better management of people with diabetes. To achieve these goals, the journal publishes original research on human studies in the following five categories: 1) Clinical Care/Education/Nutrition/Psychosocial Research, 2) Epidemiology/Health Services Research, 3) Emerging Treatments and Technologies, 4) Pathophysiology/Complications, and 5) Cardiovascular and Metabolic Risk. The journal also publishes clinically relevant review articles, letters to the editor, and health/medical news or points of view. Topics covered are of interest to clinically oriented physicians, researchers, epidemiologists, psychologists, diabetes educators, and other health professionals. .

Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.Diabetes Research and Clinical Practice is the official journal of the International Diabetes Federation.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The mission of Diabetes Spectrum: From Research to Practice is to assist health care professionals in the development of strategies to individualize treatment and diabetes self-management education for improved quality of life and diabetes control. These goals are achieved by presenting review as well as original, peer-reviewed articles on topics in clinical diabetes management, professional and patient education, nutrition, behavioral science and counseling, educational program development, and advocacy. In each issue, the FROM RESEARCH TO PRACTICE section explores, in depth, a diabetes care topic and provides practical application of current research findings.

Diabetes Technology & Therapeutics is the only peer-reviewed journal which provides healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of the latest technologies and therapeutics in the field. Each issue highlights new pharmacological and device developments to optimize patient care. The Journal fosters the development and use of new and emerging technologies to be applied to diabetes, including: Alternate insulin delivery methods Continuous glucose monitoring Artificial pancreas Computerized case management/telemedicine Detection and prevention of long-term micro- and macrovascular complicationsThe Journal publishes recent developments in pharmacologic therapy and device development with original papers, accompanied by analysis commentaries, on the performance of brand-name products.